Legis Daily

To establish and fund an Opioids and STOP Pain Initiative to expand, intensify, and coordinate fundamental, translational, and clinical research of the National Institutes of Health with respect to opioid abuse, the understanding of pain, and the discovery and development of safer and more effective treatments and preventive interventions for pain.

USA115th CongressHR-4733| House 
| Updated: 1/3/2018
Peter Welch

Peter Welch

Democratic Representative

Vermont

Cosponsors (28)
Ruben Gallego (Democratic)Jared Huffman (Democratic)Alexander X. Mooney (Republican)Peter T. King (Republican)James R. Langevin (Democratic)David N. Cicilline (Democratic)John Abney Culberson (Republican)Eliot L. Engel (Democratic)Debbie Dingell (Democratic)Steve Cohen (Democratic)Donald M. Payne (Democratic)David B. McKinley (Republican)Ro Khanna (Democratic)Elizabeth H. Esty (Democratic)Ann M. Kuster (Democratic)John B. Larson (Democratic)Anna G. Eshoo (Democratic)Conor Lamb (Democratic)Jamie Raskin (Democratic)James P. McGovern (Democratic)Julia Brownley (Democratic)Beto O'Rourke (Democratic)Earl Blumenauer (Democratic)Seth Moulton (Democratic)Suzanne Bonamici (Democratic)Evan H. Jenkins (Republican)Zoe Lofgren (Democratic)John J. Duncan (Republican)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee, Budget Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Opioids and STOP Pain Initiative Act This bill establishes and provides funds for the Opioids and STOP Pain Initiative at the National Institutes of Health (NIH) to support pain-related research, including: understanding pain, therapies for chronic pain, and alternatives to opioids for pain treatment as directed in the Comprehensive Addiction and Recovery Act of 2016; improving options and evidence for medication-assisted treatment and opioid overdose reversal treatments; and supporting the Federal Pain Research Strategy. NIH must establish the Pain Therapy Screening Program to award grants to support the development of new pre-clinical models for pain disorders, and the application of these models in drug, device, or other therapy screening.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 21, 2017

Latest Companion Bill Action

S 115-2260
Introduced in Senate
Dec 21, 2017
Introduced in House
Dec 21, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Budget, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 22, 2017
Referred to the Subcommittee on Health.
Jan 3, 2018
Referred to the Subcommittee on Health.
  • December 21, 2017

    Latest Companion Bill Action

    S 115-2260
    Introduced in Senate


  • December 21, 2017
    Introduced in House


  • December 21, 2017
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Budget, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • December 22, 2017
    Referred to the Subcommittee on Health.


  • January 3, 2018
    Referred to the Subcommittee on Health.

Health

Related Bills

  • S 115-2260: A bill to establish and fund an Opioids and STOP Initiative to expand, intensify, and coordinate fundamental, translational, and clinical research of the National Institutes of Health with respect to opioid abuse, the understanding of pain, and the discovery and development of safer and more effective treatments and preventive interventions for pain.
  • HR 115-5531: To provide for a comprehensive, multifaceted approach to preventing and treating opioid addiction.
Charitable contributionsCongressional oversightDepartment of Health and Human ServicesDrug therapyDrug trafficking and controlled substancesHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesIncome tax creditsMedical researchNational Institutes of Health (NIH)Prescription drugsResearch administration and fundingResearch and developmentSocial work, volunteer service, charitable organizationsUser charges and fees

To establish and fund an Opioids and STOP Pain Initiative to expand, intensify, and coordinate fundamental, translational, and clinical research of the National Institutes of Health with respect to opioid abuse, the understanding of pain, and the discovery and development of safer and more effective treatments and preventive interventions for pain.

USA115th CongressHR-4733| House 
| Updated: 1/3/2018
Opioids and STOP Pain Initiative Act This bill establishes and provides funds for the Opioids and STOP Pain Initiative at the National Institutes of Health (NIH) to support pain-related research, including: understanding pain, therapies for chronic pain, and alternatives to opioids for pain treatment as directed in the Comprehensive Addiction and Recovery Act of 2016; improving options and evidence for medication-assisted treatment and opioid overdose reversal treatments; and supporting the Federal Pain Research Strategy. NIH must establish the Pain Therapy Screening Program to award grants to support the development of new pre-clinical models for pain disorders, and the application of these models in drug, device, or other therapy screening.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 21, 2017

Latest Companion Bill Action

S 115-2260
Introduced in Senate
Dec 21, 2017
Introduced in House
Dec 21, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Budget, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 22, 2017
Referred to the Subcommittee on Health.
Jan 3, 2018
Referred to the Subcommittee on Health.
  • December 21, 2017

    Latest Companion Bill Action

    S 115-2260
    Introduced in Senate


  • December 21, 2017
    Introduced in House


  • December 21, 2017
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Budget, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • December 22, 2017
    Referred to the Subcommittee on Health.


  • January 3, 2018
    Referred to the Subcommittee on Health.
Peter Welch

Peter Welch

Democratic Representative

Vermont

Cosponsors (28)
Ruben Gallego (Democratic)Jared Huffman (Democratic)Alexander X. Mooney (Republican)Peter T. King (Republican)James R. Langevin (Democratic)David N. Cicilline (Democratic)John Abney Culberson (Republican)Eliot L. Engel (Democratic)Debbie Dingell (Democratic)Steve Cohen (Democratic)Donald M. Payne (Democratic)David B. McKinley (Republican)Ro Khanna (Democratic)Elizabeth H. Esty (Democratic)Ann M. Kuster (Democratic)John B. Larson (Democratic)Anna G. Eshoo (Democratic)Conor Lamb (Democratic)Jamie Raskin (Democratic)James P. McGovern (Democratic)Julia Brownley (Democratic)Beto O'Rourke (Democratic)Earl Blumenauer (Democratic)Seth Moulton (Democratic)Suzanne Bonamici (Democratic)Evan H. Jenkins (Republican)Zoe Lofgren (Democratic)John J. Duncan (Republican)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee, Budget Committee

Health

Related Bills

  • S 115-2260: A bill to establish and fund an Opioids and STOP Initiative to expand, intensify, and coordinate fundamental, translational, and clinical research of the National Institutes of Health with respect to opioid abuse, the understanding of pain, and the discovery and development of safer and more effective treatments and preventive interventions for pain.
  • HR 115-5531: To provide for a comprehensive, multifaceted approach to preventing and treating opioid addiction.
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Charitable contributionsCongressional oversightDepartment of Health and Human ServicesDrug therapyDrug trafficking and controlled substancesHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesIncome tax creditsMedical researchNational Institutes of Health (NIH)Prescription drugsResearch administration and fundingResearch and developmentSocial work, volunteer service, charitable organizationsUser charges and fees